Edition:
United Kingdom

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

618.50INR
11:29am BST
Change (% chg)

Rs8.75 (+1.44%)
Prev Close
Rs609.75
Open
Rs610.60
Day's High
Rs623.75
Day's Low
Rs607.50
Volume
1,593,058
Avg. Vol
1,409,737
52-wk High
Rs1,012.00
52-wk Low
Rs530.65

Latest Key Developments (Source: Significant Developments)

India's Wockhardt Ltd March Qtr Consol Loss Narrows
Friday, 4 May 2018 

May 4 (Reuters) - Wockhardt Ltd ::MARCH QUARTER CONSOL NET LOSS 1.55 BILLION RUPEES VERSUS LOSS OF 1.75 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 10.18 BILLION RUPEES VERSUS 8.64 BILLION RUPEES LAST YEAR.SAYS CO APPROVED ISSUANCE OF NCDS ON PRIVATE PLACEMENT BASIS UP TO 12 BILLION RUPEES.SAYS APPROVED RAISING FUNDS OF UP TO 15 BILLION RUPEES.  Full Article

India's Wockhardt posts Sept-qtr consol loss
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Wockhardt Ltd ::Sept quarter consol net loss 33.3 million rupees versus profit of 170.2 million rupees last year.Sept quarter consol revenue from operations 10.22 billion rupees versus 10.65 billion rupees last year.  Full Article

Wockhardt gets U.S. FDA approval for antibiotic injection
Monday, 7 Aug 2017 

Aug 7 (Reuters) - Wockhardt Ltd :Says Wockhardt receives US FDA approval for antibiotic injection.Says is expected to launch this product in United States, soon.Says product is being manufactured at a contract manufacturing facility, based near Milan, Italy.Says received approval from US FDA for an ANDA for 1gm, and 2gm injections of Oxacillin.  Full Article

Wockhardt says inspection at Chikalthana unit completed without critical observations
Thursday, 29 Sep 2016 

Wockhardt Ltd :Inspection of unit at l-1, Chikalthana, Aurangabad by UK MHRA completed without any critical observations.  Full Article

BRIEF-India's Wockhardt Ltd March Qtr Consol Loss Narrows

* MARCH QUARTER CONSOL NET LOSS 1.55 BILLION RUPEES VERSUS LOSS OF 1.75 BILLION RUPEES LAST YEAR